| Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer’s disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET | European journal of nuclear medicine and molecular imaging |  | | 2025 | 20 | 178 |
|
| Clinical and molecular correlates of limbic age-related TDP-43 encephalopathy (LATE) 18F-FDG-PET pattern in amnestic mild cognitive impairment | European journal of nuclear medicine and molecular imaging | | | 2025 | 21 | 688 |
|
| Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline | Brain | | | 2024 | 12 | 196 |
|
| A comparison of visual assessment and semi-quantification for the diagnostic and prognostic use of [18F]flortaucipir PET in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | | 2024 | 92 | 93 |
|
| The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline | Alzheimer's & dementia | | | 2024 | 134 | 208 |
|
| Automatic Classification of Conclusions from Multi-Tracer Reports of PET Brain Imaging in Cognitive Impairment | Studies in health technology and informatics | | | 2024 | 154 | 142 |
|
| Prognostic value of imaging-based ATN profiles in a memory clinic cohort | European journal of nuclear medicine and molecular imaging | | | 2023 | 102 | 156 |
|
| ATN profile classification across two independent prospective cohorts | Frontiers in medicine | | | 2023 | 141 | 189 |
|
| Sex differences in dementia with Lewy bodies: an imaging study of neurotransmission pathways | European journal of nuclear medicine and molecular imaging | | | 2023 | 121 | 113 |
|
| Early-phase 18F-Florbetapir and 18F-Flutemetamol images as proxies of brain metabolism in a memory clinic setting | The Journal of nuclear medicine | | | 2023 | 185 | 308 |
|
